Literature DB >> 12114710

Discordant Expression of Ii and HLA-DR in Thyrocytes: A Possible Pathogenetic Factor in Hashimoto's Thyroiditis.

Mujun Yu1, Mingzhen Xu, Lou Savas, Ashraf Khan.   

Abstract

Hashimoto's thyroiditis is the archetype of organ-specific autoimmune disease. The key pathogenetic feature is the activation of thyroid-specific T-cells by properly presented endogenous thyroid antigens. There is strong indication that thyrocytes themselves present self-antigens, based on the finding of antigen presenting human leukocyte antigen-DR (HLA-DR) molecules on the thyrocytes in Hashimoto's thyroiditis. Because class ll-associated invariant chain (Ii) is tightly bound to the antigen-binding groove of the DR molecules in the endoplasmic reticulum and is found to compete with the endogenous peptides for binding with DR. it is speculated that Ii prevents endogenous peptides from binding to, and being presented by, DR on the cell surface. We hypothesize that in Hashimoto's thyroiditis, Ii is insufficient, leaving DR molecules open for endogenous peptides, In this article, we test our hypothesis of discordance between DR and Ii in the thyroid epithelial cells in Hashimoto's thyroiditis by immunohistochemistry. Formalin-fixed, paraffin-embedded archival tissue from eight cases of Hashimoto's thyroiditis and four cases of normal thyroid specimen were randomly selected and immunostained with monoclonal antibodies (MAbs) against HLA-DR and Ii using avidin-biotin-peroxidase method. We found that in all eight cases of Hashimoto's thyroiditis. Ii is significantly reduced relative to DR. The results support our hypothesis that presentation of self-antigen may be a result of insufficient Ii in the thyrocytes in Hashimoto's thyroiditis.

Entities:  

Year:  1998        PMID: 12114710     DOI: 10.1007/bf02739959

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  39 in total

Review 1.  A perspective on human autoimmune thyroid disease: is there an abnormality of the target cell which predisposes to the disorder?

Authors:  R Volpé
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

2.  Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.

Authors:  V E Reyes; S Lu; R E Humphreys
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

3.  MHC class II-restricted presentation of intracellular antigen.

Authors:  S Weiss; B Bogen
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

4.  HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.

Authors:  S Jacobson; R P Sekaly; C L Jacobson; H F McFarland; E O Long
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-kappa B-like factor to a promoter element.

Authors:  U Pessara; N Koch
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

6.  Interferon-gamma, mitomycin C, and cycloheximide as regulatory agents of MHC class II-associated invariant chain expression.

Authors:  H J Rahmsdorf; N Harth; A M Eades; M Litfin; M Steinmetz; L Forni; P Herrlich
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

7.  The invariant chain of murine Ia antigens: its glycosylation, abundance and subcellular localization.

Authors:  E Sung; P P Jones
Journal:  Mol Immunol       Date:  1981-10       Impact factor: 4.407

Review 8.  Pathogenic mechanisms in autoimmune diseases.

Authors:  N R Rose
Journal:  Clin Immunol Immunopathol       Date:  1989-11

Review 9.  Autoimmune thyroid disease: further developments in our understanding.

Authors:  A P Weetman; A M McGregor
Journal:  Endocr Rev       Date:  1994-12       Impact factor: 19.871

10.  Induction of the murine class-II antigen-associated invariant chain by TNF-alpha is controlled by an NF-kappa B-like element.

Authors:  D P Kolk; G Floyd-Smith
Journal:  Gene       Date:  1993-04-30       Impact factor: 3.688

View more
  2 in total

1.  Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Authors:  Azizul Haque; Laela M Hajiaghamohseni; Ping Li; Katherine Toomy; Janice S Blum
Journal:  Cell Immunol       Date:  2007-12-11       Impact factor: 4.868

2.  Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy.

Authors:  S P Finn; P Smyth; S Cahill; C Streck; E M O'Regan; R Flavin; J Sherlock; D Howells; R Henfrey; M Cullen; M Toner; C Timon; J J O'Leary; O M Sheils
Journal:  Virchows Arch       Date:  2007-01-25       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.